SEEL Seelos Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders.
On 3/14/2022 B. Riley Lower Price Target Buy rating for SEEl from $6.00 to $4.00.
52 Week Range 0.76 - 6.60
Is this a strong buy? Looking...
